← Back to all trials
Recruiting
NCT07486518
A Multicentre Observational Cross-Sectional Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India
Conditions: Gastric Adenocarcinoma, Early Gastric Cancer
Sex: All
Ages: 40 Years – N/A
Healthy volunteers: Yes
Enrollment: 4000
Sponsor: Asian Institute of Gastroenterology, India
Location: AIG Hospitals Hyderabad Telangana
Summary
To estimate the prevalence of histologically confirmed early gastric cancer (EGC) in an Indian multicentre cohort undergoing standardised high-quality upper gastrointestinal endoscopy. EGC is defined as gastric adenocarcinoma confined to the mucosa or submucosa (T1), irrespective of lymph node status, based on histopathology.
Eligibility Criteria
1. Adults aged ≥40 years undergoing upper gastrointestinal endoscopy for dyspepsia or other clinical indications (nonalarming and alarming symptoms both).
2. Ability to provide written informed consent.
Exclusion Criteria:
1. Known gastric malignancy.
2. Prior gastric surgery (excluding H. pylori eradication).
3. Contraindications to endoscopy or biopsy.
4. Known hereditary gastric cancer syndromes.
Source: ClinicalTrials.gov (NCT07486518). StuddyBuddy aggregates publicly available trial information.
